The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alao JP . (2007). The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24.
An D, Kewalramani G, Chan JK, Qi D, Ghosh S, Pulinilkunnil T et al. (2006). Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetologia 49: 2174–2184. Epub 2006 Jul 26.
Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binetruy B, Bost F . (2006). Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55: 281–289.
Bost F, McKay R, Bost M, Potapova O, Dean NM, Mercola D . (1999). The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol Cell Biol 19: 1938–1949.
Bost F, McKay R, Dean NM, Potapova O, Mercola D . (2000). Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family. Methods Enzymol 314: 342–362.
Campbell IW . (1985). Metformin and the sulphonylureas: the comparative risk. Horm Metab Res Suppl 15: 105–111.
Chen Y, Martinez LA, LaCava M, Coghlan L, Conti CJ . (1998). Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. Oncogene 16: 1913–1920.
Collins SP, Reoma JL, Gamm DM, Uhler MD . (2000). LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345: 673–680.
Dagon Y, Avraham Y, Berry EM . (2006). AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 340: 43–47.
Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA et al. (2006). Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer. Cancer Res 66: 11897–11906.
Denmeade SR, Isaacs JT . (2004). Development of prostate cancer treatment: the good news. Prostate 58: 211–224.
Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N et al. (2005). Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes 54: 2179–2187.
Diehl JA, Cheng M, Roussel MF, Sherr CJ . (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499–3511.
Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C . (2000). Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 6: 1891–1895.
El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X . (2000). Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275: 223–228.
Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y et al. (2006). Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells. Biochem Pharmacol 72: 427–436.
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD . (2005). Metformin and reduced risk of cancer in diabetic patients. BMJ 330: 1304–1305.
Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D et al. (2006). 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55: 865–874.
Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB . (1998). Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 35: 95–101.
Hardie DG . (2003). Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179–5183.
Hawley SA, Gadalla AE, Olsen GS, Hardie DG . (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420–2425.
Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F et al. (2004). Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23: 7863–7873.
Ibanez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F . (2006). Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 91: 2888–2891.
Kahn BB, Alquier T, Carling D, Hardie DG . (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15–25.
Kim WH, Lee JW, Suh YH, Lee HJ, Lee SH, Oh YK et al. (2007). AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell Signal 19: 791–805.
Libertini SJ, Tepper CG, Guadalupe M, Lu Y, Asmuth DM, Mudryj M . (2006). E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis. Prostate 66: 70–81.
Lord JM, Flight IH, Norman RJ . (2003). Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327: 951–953.
Loubat A, Rochet N, Turchi L, Rezzonico R, Far DF, Auberger P et al. (1999). Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest. Oncogene 18: 3324–3333.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N . (2001). Metformin in non-alcoholic steatohepatitis. Lancet 358: 893–894.
Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY . (1994). D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066–2076.
Park C, Lee I, Kang WK . (2006). Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis. Mol Cancer Ther 5: 3191–3196.
Perry JE, Grossmann ME, Tindall DJ . (1998). Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line. Prostate 35: 117–124.
Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL . (1996). The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab 81: 3709–3716.
Ruderman NB, Park H, Kaushik VK, Dean D, Constant S, Prentki M et al. (2003). AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand 178: 435–442.
Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ et al. (2001). Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 120: 1263–1270.
Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C et al. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804–810.
Sherr CJ, Roberts JM . (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149–1163.
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M . (2006). Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66: 10269–10273.
Zhang Y, Howell RD, Alfonso DT, Yu J, Kong L, Wittig JC et al. (2007). IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells. Front Biosci 12: 4855–4863.